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Abstract
Background: Adiponectin is an adipocyte-secreted hormone with insulin-sensitizing and anti-inflammatory actions.
The assembly of trimeric, hexameric, and higher molecular weight (HMW) species of adiponectin is a topic of
significant interest because physiological actions of adiponectin are oligomer-specific. In addition, adiponectin
assembly is an example of oxidative oligomerization of multi-subunit protein complexes in endoplasmic reticulum
(ER).
Results: We previously reported that trimers assemble into HMW adiponectin via intermediates stabilized by
disulfide bonds, and complete oxidation of available cysteines locks adiponectin in hexameric conformation. In this
study, we examined the effects of redox environment on the rate of oligomer formation and the distribution of
oligomers. Reassembly of adiponectin under oxidizing conditions accelerated disulfide bonding but favored
formation of hexamers over the HMW species. Increased ratios of HMW to hexameric adiponectin could be
achieved rapidly under oxidizing conditions by promoting disulfide rearrangement.
Conclusions: Based upon these observations, we propose oxidative assembly of multi-subunit adiponectin
complexes in a defined and stable redox environment is favored under oxidizing conditions coupled with high
rates of disulfide rearrangement.
Background
The adipocyte-secreted hormone adiponectin contri-
butes to the maintenance of whole body insulin action
and normal cardiovascular and endothelial functions
[1-7]. Adiponectin homo-oligomerizes into different iso-
forms: trimer, hexamer and several higher molecular
w e i g h t( H M W )s p e c i e s ,t h el a r g e s ta n dt h em o s ta b u n -
dant of which is the octadecamer [8-10]. Trimeric adi-
ponectin, the basic building block of all oligomers, is
held together by strong hydrophobic interactions among
the three monomers in the globular head domain and
by triple helical coils in the collagenous domain [11].
The HMW adiponectin species are decreased in insulin
resistance to a larger extent than the other isoforms
[12-16]. In contrast, treatment with thiazolidinediones
(TZD), a class of drugs that are used for treatment of
type 2 diabetes, increases HMW adiponectin
concentration in circulation [16,17]. Changes in gene
expression alone could not account for TZD-stimulated
increase in HMW adiponectin levels [17], therefore it is
important to understand the mechanisms that impair
the formation of HMW adiponectin in adipocytes.
Disulfide bonds play an important role in the oligo-
merization of adiponectin. Adiponectin contains two
conserved cysteines: one in the globular head of adipo-
nectin and the one at the N-terminal portion [10]. Pre-
vious studies have shown that the non-solvent accessible
cysteine in the globular head of adiponectin does not
influence adiponectin oligomerization [10], whereas the
cysteine near the N-terminus (C22 residue in mature
murine adiponectin) mediates oligomerization into the
hexamer and octadecameric isoforms of adiponectin
[10,18,19]. The trimeric isoform of adiponectin contains
a dimer linked by an intra-trimer disulfide bond and a
monomer [10]. In contrast, the cysteines in N-terminal
regions of adiponectin hexamers and octadecamers are
fully oxidized as disulfides [10]. In previous studies,
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formation of the higher-ordered oligomers [10,18,19].
Intriguingly, recent gel filtration chromatography
showed that large complexes of adiponectin could exist
following treatment with reducing agents [20]. Using
high resolution gel electrophoresis, dynamic light scat-
tering, and collision-induced dissociation nano-electro-
spray ionization mass spectrometry, we showed
definitively that octadecameric HMW adiponectin is
stable in absence of disulfide bonds [21]. We addressed
this paradox in our previous report by demonstrating
that although disulfide bonds are not required for stabi-
lity of the mature HMW species, they are necessary for
oligomerization [21]. Disulfide bonds likely provide the
covalent linkages needed to stabilize intermediate oligo-
mers in the step-wise addition of subunits during the
expansion of oligomers. Consistent with this conclusion,
fully oxidized adiponectin hexamers lacking free thiols
assembled into octadecamers at an extremely slow rate
when compared with that of reduced trimers under-
going disulfide formation during assembly [21].
Given the importance of disulfide bonds in the assem-
bly of HMW adiponectin, we hypothesized that redox
conditions can affect the distribution of adiponectin oli-
gomers through changes in the rate of and pattern of
disulfide formation. To test this hypothesis, we moni-
tored oligomerization of adiponectin under various
redox conditions. Under conditions with low reduction
potential, adiponectin did not undergo oxidative assem-
bly in a physiologically relevant time frame. Under oxi-
dizing conditions, the predominant oligomers were
hexamers and trimers that oligomerized poorly into lar-
ger species. We found that conditions favoring rearran-
gement of disulfide bonds led to robust and relatively
rapid formation of HMW adiponectin. Taken together,
our data provide a redox-based model for oxidative
assembly of a multi-subunit adiponectin protein com-
plex and may implicate ER redox environment alteration
as a contributing factor in decreased levels of HMW
adiponectin in insulin-resistant disease states. Our data
also provide potential mechanisms for understanding
the previously observed effects of the ER oxidoreductase
Ero1-La and chaperones DsbA-L and ERp44 on adipo-
nectin production [22-24].
Results
Effect of slower oxidation rate on oligomer distribution
during adiponectin re-oligomerization
We previously showed the main function of disulfide
bonds in oxidative oligomerization of adiponectin is to
stabilize intermediate oligomers and that fully oxidized
hexamers oligomerized to HMW adiponectin at a much
slower rate than reduced trimers [21]. This led us to
hypothesize that adiponectin oligomerization into HMW
or hexameric isoforms could be modulated by the pre-
vailing redox environment. Specifically, our model pre-
dicts that oxidizing conditions will accelerate disulfide
bonding and favor the formation of fully oxidized hex-
amers that are unable to assemble further into HMW
adiponectin. To test this hypothesis, we performed re-
oligomerization experiments in which the rate of disul-
fide formation was slowed by decreasing the rate of
DTT removal. Following collapse to trimers by reduc-
tion with 5 mM DTT and lowering of pH to 4, reassem-
bly of HMW adiponectin was examined as reactions
were exchanged into varying concentrations of DTT in
PBS at pH 7.4. As reactions were dialyzed into increas-
ing concentrations of DTT, decreased formation of both
octadecameric and hexameric adiponectin were
observed, with hexamer formation affected to a greater
extent than octadecamer formation (Figure 1A). The
increased susceptibility of hexamers to reduction could
be explained by the inherent stability of reduced octade-
camer [21]. Alternatively, the inter-trimer disulfide
bonds between hexamers are more susceptible to reduc-
tion than those in the HMW complex [18]. Formation
of octadecamers and hexamers was accompanied by oxi-
dation of reduced monomers to disulfide-bonded dimers
(Figure 1B). As the concentration of DTT increased, the
amount of reduced monomer increased at the expense
of oxidized dimer, indicating reduced rates of disulfide
formation (Figure 1B). This increase in reduced mono-
mers compared to oxidized dimers is accompanied by a
decrease in the conversion of trimers to larger species
(Figure 1A). These results demonstrate that decreased
rate of disulfide bonding led to decreased formation of
both HMW and hexameric adiponectin formation.
Complete removal of DTT did not inhibit HMW adipo-
nectin formation at the expense of hexamers (Figure
1A). These results do not support the notion that mod-
ulating the rate of disulfide bond formation could result
in preferential formation of HMW adiponectin over
hexamers or vice versa.
Defining the reduction potential of adiponectin
oligomerization
To better define the role of redox environment on adipo-
nectin oligomerization, we performed re-oligomerization
experiments in a series of glutathione-based redox buffers
with varying reduction potentials bracketing the reported
ER reduction potential of -180 mV [25]. In these experi-
ments, DTT added to reduce purified octadecamers was
removed prior to start of reassembly reactions by addition
of oxidized glutathione. For each reduction potential, pilot
experiments were first performed to ensure sufficient time
was given to allow adiponectin redox state to reach equili-
brium (data not shown). To minimize the effect of
oxygen on oxidation, DTT removal and subsequent
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chamber. In contrast to the results in Figure 1 in which
re-assembly was allowed to proceed by slow and gradual
removal of reducing agents, in these experiments reducing
agents were removed before re-oligomerization began by
incubation in glutathione-based buffers, resulting in
decreased levels of HMW adiponectin relative to hexamers
or trimers under all redox conditions tested (Figure 2A).
Oxidation of adiponectin reached equilibrium faster and
to a larger extent as the reduction potential increased
from -220 to -120 mV (Figure 2B). At -220 and -200 mV,
the rate of adiponectin oxidation was slowest and the con-
centrations of reduced monomers the highest among the
reduction potentials tested (Figure 2B). Trimers predomi-
nated under these conditions (Figure 2A). At -140 and
-120 mV, nearly all adiponectin molecules became disul-
fide-bonded within 2 hrs of incubation and majority of
reassembled oligomers were hexamers (Figure 2A and 2B).
At -180 and -160 mV, the rate and extent of adiponectin
oxidation were moderate compared with either extremes,
yet the predominant oligomers were trimers or hexamers
with small amounts of HMW adiponectin upon prolonged
incubation (Figure 2A and 2B). These data indicate that in
the physiologically relevant glutathione redox buffer with
reduction potentials ranging from -220 to -120 mV, oxida-
tion was either too slow to promote significant formation
of HMW adiponectin in a reasonable time frame or too
fast to allow intermediates to grow by forming additional
disulfide bonds before becoming completely oxidized.
Inability of adiponectin trimers to oligomerize under
highly oxidizing conditions
One potential explanation for lack of HMW adiponectin
formation in glutathione based redox buffers is
Figure 1 Re-oligomerization of adiponectin following dialysis into defined concentrations of DTT. (A) Native PAGE of adiponectin
oligomers after collapse to trimers and subsequent re-oligomerization as concentrations of DTT were equilibrated from 5 mM to 0.008, 0.04, 0.2,
1, or 5 mM by dialysis over an 18-hr period. (B) Non-reducing denaturing SDS-PAGE analysis to identify the oxidation state of adiponectin as
either in the disulfide-bonded dimer state or reduced monomer state in each of the different conditions. Oligomerization and oxidation states
were examined at 6 and 18 hrs. The redox state of adiponectin was fixed by adding NEM to the sample at the end of reassembly reactions. 3
mer: trimer; 6 mer: hexamer; 9 mer: nonamer; 12 mer: dodecamer; 18 mer: octadecamer. The number of monomers in trimers, hexamers, and
octadecamers in native gels were independently verified using native mass spectrometry and gel filtration chromatography (data not shown).
The number of monomers in nonamers and dodecamers were determined by extrapolation of migration distances of known oligomers in native
gels as described in Methods.
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reduction potential, significant amounts of adiponectin
monomers remained (Figure 2B). These monomers
could be in either the glutathionylated or free thiol
forms, and likely form the trimers that were also present
at significant levels at -120 mV (Figure 2A). To assure
that the reduction potential was high enough to comple-
tely oxidize adiponectin, we repeated adiponectin reas-
sembly experiments at reduction potentials as high as
+40 mV, and found that hexamers were still the predo-
minant species and small amounts of adiponectin mono-
mers remained (Additional file 1: Figure S1A and S1B).
Adiponectin monomers that remained at high reduc-
tion potentials might be glutathionylated. To address
the possibility that glutathionylated adiponectin has a
higher reduction potential than disulfide-bonded adipo-
nectin, we used diamide, which oxidizes adiponectin
without mixed disulfide formation, as the oxidizing
agent in our re-oligomerization reactions. As shown in
Figure 3, 25 mM diamide added to reduced trimers
failed to completely oxidize adiponectin, as evidenced by
abundant monomers following diamide treatment (Fig-
ure 3B), and resulted in much of the adiponectin
trapped in trimers rather than proceeding to HMW adi-
ponectin (Figure 3A). These data suggest that the
remaining cysteine in partially oxidized adiponectin tri-
mer (consisting of a disulfide bonded dimer and a
reduced monomer) has an unusually high reduction
potential; very tiny amounts of reduced glutathione are
all that is required to keep it reduced. If the remaining
cysteine in a partially oxidized trimer is buried and inac-
cessible to solvent, it could result in it having a high
reduction potential. Partially oxidized adiponectin trimer
may exist in a conformation that precludes oligomeriza-
tion, which could contribute to impaired assembly of
HMW adiponectin under highly oxidizing conditions.
Figure 2 Redox titration of adiponectin oligomerization in glutathione-based redox buffers. (A) Native PAGE of adiponectin oligomers
after collapse to trimers and subsequent incubation in various reduction potentials and time points as indicated. (B) Non-reducing denaturing
SDS-PAGE analysis of disulfide-bonded dimers or reduced monomers at various time points. Purified bovine octadecameric adiponectin was
collapsed to trimers as described in Methods. After collapse, different ratios of oxidized and reduced glutathione at reduction potentials ranging
from -120 to -220 mV were added and allowed to incubate in an anaerobic chamber for up to 48 hrs. The total concentration of glutathione in
each condition ranged from 1 to 3 mM. At each time point, aliquots were removed and further disulfide bond exchange was halted by
treatment with NEM.
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rearrangement
T h ed a t ap r e s e n t e da b o v ei n d i c a t et h a to x i d a t i o no f
reduced adiponectin trimers proceeds faster under oxi-
dizing conditions, and that under these conditions hex-
amers are the predominant adiponectin oligomer.
However, assembly of HMW adiponectin could occur
over time in absence of net adiponectin oxidation under
many conditions tested. In Figure 2, HMW adiponectin
accumulated over time at -160 mV without overt
changes in the ratio of dimers to monomers, suggesting
that adiponectin oligomerization could proceed under
oxidizing conditions via disulfide rearrangement. We
therefore tested whether increasing concentrations of
glutathione at a fixed redox potential could enhance adi-
ponectin oligomerization by promoting disulfide rear-
rangement. Increasing concentrations of total
glutathione but maintaining the reduction potential
constant at -120 mV led to increased ratios of HMW
versus hexameric adiponectin (Figure 4A). In reactions
with higher total glutathione concentrations, the
increased levels of octadecamers were associated with
decreased levels of hexamers and trimers (Figure 4A).
The levels of adiponectin dimers and monomers did not
significantly change with increasing concentrations of
total glutathione (Figure 4B), indicating net oxidation
states were not altered by glutathione levels. Addition-
ally, glutathionylation of adiponectin increased with
higher concentrations of total glutathione, consistent
with increased disulfide rearrangement (Figure 4C and
4D).
To further assess if disulfide rearrangement leads to
oligomerization into HMW adiponectin, we first pre-
pared oxidized hexamers by reducing the pH of the pur-
ified octadecamers to 4 in absence of reducing agents.
Subsequently, varying concentrations of bME were
added to partially reduce adiponectin and allow disulfide
rearrangement to occur. After amounts of reduced adi-
ponectin reach equilibrium following addition of bME,
any oligomerization that takes place in absence of net
oxidation or reduction is most likely the result of disul-
fide rearrangement. Interestingly, 100 μM bME led to
immediate reduction of small amounts of adiponectin
without promoting immediate octadecamer formation
(Figure 5A and 5B). However, after 60 min of incuba-
tion, the octadecamer began to assemble, and continued
to increase until 240 min (Figure 5A). During this time
period the concentrations of oxidized dimers and
reduced monomers remained constant (Figure 5B), indi-
cating lack of net oxidation or reduction. Similar pat-
terns of adiponectin assembly and oxidation were
observed with the addition of 500 μM bME (Figure 5A
a n d5 B ) .A t5m MbME, HMW species re-oligomerized
within 5 min (Figure 5A).
The hexamers in Figure 5A and 5B migrated in a dif-
fuse manner in native gels. In contrast to previous
experiments in which the glycine used for octadecamer
collapse was either removed by dialysis or diluted in
PBS, the combination of the use of Tris-base to neutra-
lize the reactions and the presence of high concentra-
tions of glycine likely caused hexamers to migrate
diffusely. To demonstrate that hexamers indeed
decreased at the expense of HMW and trimeric adipo-
nectin following reduction by bME, separate experi-
ments were performed in which the reactions were
dialyzed against PBS at pH 7 for 3 hrs prior to addition
of bME. As shown in Figure 5C and 5D, upon neutrali-
zation by dialysis, 5 mM bME led to decreased levels of
hexamers along with increased octadecamers and tri-
mers, indicating reduction of hexamers and reassembly
of adiponectin octadecamers. In general, increased pro-
portions of reduced adiponectin resulted in faster re-
Figure 3 Re-oligomerization of adiponectin following diamide
treatment. (A) Native PAGE of adiponectin oligomers after
treatment with diamide followed by dialysis into PBS. (B) Non-
reducing SDS-PAGE analysis of oxidized dimers and reduced
monomers at indicated time points. Bovine octadecameric
adiponectin was collapsed to trimers as described in Methods.
Subsequently, the samples were treated with PBS or 25 mM
diamide and allowed to dialyze against PBS for the indicated
amount of time. To fix the redox state of adiponectin, NEM was
added and stored at 4°C until analysis.
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Page 5 of 12Figure 4 Re-oligomerization of adiponectin in 2, 5, 10, and 15 mM total glutathione at a constant reduction potential of -120 mV. (A)
Native PAGE of adiponectin oligomers after collapse and subsequent incubation in various concentrations of glutathione kept at a reduction
potential of -120 mV. (B) Non-reducing denaturing SDS-PAGE analysis of disulfide-bonded dimers and reduced monomers of the same reactions.
(C) Western blot analysis of adiponectin glutathionylation under non-reducing denaturing conditions. Anti-glutathione primary antibody was
purchased from Arbor Assays. (D) Ponceau S stain of the blot in C prior to blocking. Purified bovine octadecamer was collapsed to trimers as
described in Methods. After collapse and removal of DTT, adiponectin was allowed to re-oligomerize in the presence of 2, 5, 10, or 15 mM total
glutathione concentrations held at a constant reduction potential of -120 mV. Experiments were performed in anaerobic conditions to minimize
the oxidizing effects of atmospheric oxygen. At each time point, NEM was added prior to removal of samples from anaerobic chamber. a-GSH:
anti-GSH antibody; GS-Monomer: glutathionylated monomer.
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higher levels of octadecameric and trimeric species at
the expense of hexamers, pointing to disulfide rearran-
gement facilitating adiponectin oligomerization.
Discussion
Low serum levels of HMW adiponectin are associated
with obesity and insulin resistance [12-16]. It has been
suggested that this selective decrease is due to a subop-
timal folding environment in the ER [26]. We have
attempted to analyze the de novo formation of HMW
adiponectin from the trimer in order to build a detailed
model of adiponectin assembly that could explain in
vivo data at molecular detail and to suggest additional
cell-based experiments to validate the model. Recently,
we reported that oligomerization to HMW adiponectin
occurs through partially reduced intermediates stabilized
by disulfide bonds [21]. The results led us to postulate
that excessively oxidizing conditions would accelerate
disulfide bonding and favor the formation of fully oxi-
dized hexamers that are unable to assemble further into
HMW adiponectin. Conversely, an optimal redox condi-
tion that balances a moderately reducing redox potential
with a sufficiently rapid rate of oxidation would lead to
Figure 5 Re-oligomerization of hexameric adiponectin after treatment with bME.(A) Native PAGE of adiponectin oligomers after collapse
of octadecamers to hexamers at pH 4 and subsequent neutralization in Tris-buffer and treatment with various concentrations of bME. (B) Non-
reducing denaturing SDS-PAGE analysis of adiponectin dimers and monomers in reassembly reactions in part A. (C) Native PAGE analysis of
adiponectin oligomers after collapse of octadecamers to hexamers at pH 4 and re-neutralization by dialysis against PBS followed by subsequent
treatment with either 5 mM bME or PBS as control. (D) Non-reducing denaturing SDS-PAGE analysis of redox states of adiponectin oligomers in
part C. Samples were removed and treated with NEM at the various time points to quench reactions.
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timely manner. To test these hypotheses, we monitored
oligomerization of adiponectin under various redox con-
ditions. Surprisingly, we did not find such an optimal
redox condition. Redox potentials were either too low to
lead to significant oxidative assembly in a physiological
relevant time frame or too high to generate high
amounts of HMW adiponectin. Large amounts of
HMW adiponectin were possible only when reassembly
reactions were carried out under oxidizing conditions in
which disulfide rearrangement could occur rapidly.
Several lines of evidence indicate that disulfide rear-
rangement is crucial for assembly of HMW adiponectin.
First, increasing total glutathione concentrations under
oxidizing conditions led to increased formation of
HMW adiponectin (Figure 4). Second, hexamers unable
to oligomerize into HMW adiponectin could do so after
some of the disulfide bonds in hexamers were reduced,
resulting in appearance of trimers and octadecamers
(Figure 5). Third, majority of intracellular adiponectin
exists as hexamers or trimers [20]. It is possible that dis-
ulfide rearrangement represents the rate-limiting step in
converting hexamers to HMW species. Lastly, whereas
slow rates of disulfide bond formation during gradual
removal of reducing agents led to robust reassembly of
HMW adiponectin (Figure 1), complete removal of
reducing agents followed by rapid oxidation favored
hexamers (Figures 2 and Additional file 1: Figure S1). In
our previous study, reassembly of large amount of
HMW adiponectin was possible because the oxidizing
agent used in many of the experiments, hydrogen perox-
ide, was introduced into reactions slowly by dialysis [21].
Rapid disulfide exchange was possible under these con-
ditions in which oxidation occurred slowly at first but
allowed to reach completion following complete removal
of reducing agents.
Under highly oxidizing conditions, sizable amounts of
trimers were unable to oligomerize further into either
hexamers or HMW adiponectin (Figures 3 and Addi-
tional file 1: Figure S1). These trimers likely contain
intra-trimer disulfide bonds that do not allow formation
of higher-order oligomers. Adiponectin contains a col-
l a g e nd o m a i nt h a tf o r m sat r i p l eh e l i xa m o n gt h r e e
monomers, although the architecture of the collagen
domains in the higher-order adiponectin oligomers
remains unknown. Formation of a disulfide bond within
a trimer could lock the conformation of the collagen
domain and limits the flexibility of the triple helical coil
at the N-terminal end of the molecule. If an intra-trimer
disulfide bond forms before an inter-trimer disulfide
bond, further oligomerization may be halted. Alterna-
tively, if inter-trimer disulfide bonds form before intra-
trimer disulfide bonds, then additional oligomerization
could take place. Disulfide rearrangement could facilitate
oligomerization by exchanging intra-trimer disulfide
bonds with inter-trimer disulfide bonds.
In addition to conformational constraints described
above, the inability of adiponectin trimers to assemble
into larger oligomers could be caused by inaccessibility
of the unpaired cysteine near the N-terminus to solvent.
While direct evidence in support of this hypothesis is
currently lacking, prior work indicates that isolated tri-
mers do not assemble into larger species spontaneously.
We have previously transfected HEK 293T cells with
mouse adiponectin cDNA in an expression vector and
purified adiponectin oligomers secreted from transfected
cells [9]. In addition to hexamers and octadecamers, tri-
mers were also secreted from transfected 293T cells.
These trimers were shown to consist of one monomer
and one disulfide-bonded dimer [10] and did not con-
vert to another oligomer following purification by ion
exchange and gel filtration chromatography [9]. In addi-
tion, it was previously shown that when semi-purified
human serum adiponectin trimers were injected into
rabbit veins, there was no conversion to other oligomers
in blood after 30 hrs [27].
Even though redox conditions were relatively reducing
in both Figure 5 (after bME addition) and the rightmost
panel of Figure 2, the distribution of oligomers differed.
Rearrangement of hexamers in Figure 5 led to predomi-
nantly octadecamers while reassembly from trimers at
- 2 0 0a n d- 2 2 0m Vd i dn o tl e a dt os i g n i f i c a n ta m o u n t s
of octadecamers (Figure 2A). This likely reflects kinetic
differences in the rate of oligomerization. When two
hexamers collide and undergo disulfide rearrangement,
the products are likely one nonamer (9 mer) and one
trimer. In general, disulfide rearrangements between a
growing oligomer with a hexamer will result in an even
larger oligomer and a trimer. This is supported by
results in Figure 5 in which the assembly of octadeca-
mers from hexamers invariably led to formation of tri-
mers. In contrast, when a growing oligomer collides
with a trimer and undergoes rearrangement (as in Fig-
ure 2A), the products are a rearranged oligomer of ori-
ginal size and a trimer that used to be part of a larger
oligomer. As a result, assembly from hexamers should
be significantly faster than from trimers. Given the
importance of hexamer as an intermediate in the assem-
bly of octadecamer, redox regulation of hexamer forma-
tion is likely a highly important aspect of adiponectin
oligomerization.
Results in Figure 1 and in our prior publication [21]
led us to propose that self-assembly of adiponectin octa-
decamers proceeds spontaneously through partially
reduced intermediates. This conclusion requires re-
examination in light of current results showing trapping
of adiponectin oligomerization at trimeric and hexame-
ric states in oxidizing environment (Figures 2 and 3).
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disulfide bonds to stabilize intermediate oligomers. Thus
the question of whether adiponectin oligomerization is a
spontaneous process depends on whether disulfide bond
formation in adiponectin is spontaneous. Redox reac-
tions consist of two half-reactions, one oxidizing and
the other reducing, thus disulfide formation cannot take
place unless oxidizing equivalents are present along with
reduced thiols. Disulfide bond formation is spontaneous
in the presence of electron acceptors with higher reduc-
tion potential. In the adiponectin reassembly and oxida-
tion experiments in which reducing agents were
removed gradually by dialysis (Figure 1), the identity of
the immediate electron acceptor is not clear although
we hypothesize that molecular oxygen was the ultimate
electron acceptor. Reduction of molecular oxygen to
water has a high standard reduction potential of 0.85 V
[28], making oxidation of thiols to disulfides a highly
favored and spontaneous process. In subsequent experi-
ments where oxidized glutathione and diamide are elec-
tron acceptors (Figures 2 and 3, respectively), we
observed that presence of electron acceptors with high
reduction potential is not sufficient for oligomerization
to octadecamer. Assembly of adiponectin likely follows
the well-established free energy funnel paradigm for
protein folding [29,30]. As an intermediate oligomer
grows by forming disulfide bonds with additional subu-
nits, it may fall into one of the numerous local minima
in the energy landscape. It is possible that to get out
from a low energy trap, an assembly intermediate needs
to be reduced once again. In this case oligomerization of
adiponectin octadecamers would appear to be sponta-
neous under conditions where disulfide rearrangement
could take place.
These in vitro results suggest the need to protect adi-
ponectin from forming intra-trimer disulfide bonds in
vivo. ERp44 and DsbA-L are ER chaperones that were
previously shown to influence adiponectin oligomer dis-
tribution [22,24]. ERp44 forms mixed disulfides with
adiponectin [24], which could prevent intra-trimer disul-
fide formation. The role of glutathionylation in increas-
ing oligomerization of the octadecamer under oxidizing
conditions (Figure 4) could be analogous to the role of
ERp44 in forming mixed disulfides with adiponectin in
vivo. DsbA-L contains a SXXS motif in its thioredoxin-
like domain instead of CXXC [22]. The hydroxyl groups
in DsbA-L may protect thiol groups from adjacent adi-
ponectin monomers from forming a disulfide bond.
Decreased production of total and HMW adiponectin
associated with insulin resistance may be due in part to
decreased cellular levels of ERp44 and DsbA-L. A 50%
reduction in serum HMW adiponectin was associated
with an approximately 80% decrease in adipose tissue
ERp44 in the genetically obese and insulin-resistant ob/
ob mice [24]. Decreased serum and adipose tissue adipo-
nectin were also associated with decreased amounts of
adipose tissue DsbA-L protein and mRNA in mice fed a
high-fat diet [22]. In a small cohort of humans, total
serum adiponectin concentrations were positively corre-
lated with adipose tissue DsbA-L mRNA expression and
protein levels of DsbA-L were found to be reduced in
obese and overweight individuals [22]. In contrast, treat-
ment with peroxisome proliferator-activated receptor-
gamma (PPARg) agonists, commonly prescribed anti-
diabetic medication known to increase insulin sensitivity
and serum HMW adiponectin [16], increased ERp44
and DsbA-L protein concentrations in, respectively,
mouse adipose tissue [24] and cultured adipocytes [22].
It is unclear at the present if decreased levels of
ERp44 and DsbA-L associated with obesity and insulin
resistance represent particular manifestations of overall
dysfunction in the ER compartment. ER stress charac-
terized by induction of unfolded protein response takes
place in adipocytes and hepatocytes of obese animals
and contributes to the development of insulin resistance
[31]. It is possible that obesity-related decrease in HMW
adiponectin production is in part due to ER stress inde-
pendent of changes in ERp44 or DsbA-L. This could
occur as chaperones like BiP are tasked to shield
increasing amounts of unfolded proteins and making
them unavailable to assist in the proper folding of adi-
ponectin. In addition, it was shown recently that onset
of pharmacologically- or nutritionally-induced ER stress
in yeast led to a more reducing ER redox state [32]. If
induction of unfolded protein response in adipocytes is
also accompanied by a more reduced ER redox environ-
ment, it could affect the rates of disulfide bond forma-
tion and/or rearrangement during assembly of HMW
adiponectin oligomers. It is possible that impaired adi-
ponectin oligomerization associated with insulin resis-
tance is linked by an altered ER redox state.
Conclusions
This report further analyzes the role of disulfide bond
formation in adiponectin oligomerization. Our results
emphasize the importance of conditions that promote
inter-trimer disulfide bonds, including an oxidizing
redox environment with sufficient amounts of redox
couples for disulfide rearrangement, suggesting that reg-
ulation of redox environment in adipocytes is a potential
target for future treatments against type 2 diabetes.
Methods
Oligomerization state of reassembled adiponectin
following dialysis into defined concentrations of DTT
Adiponectin octadecamers with minor amounts of hex-
amers were purified from bovine serum as previously
described [21]. Purified adiponectin at 0.25 mg/mL was
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C, followed by addition of glycine (final concentration
5 0m M )t ol o w e rt h ep Ht oa r o u n d4a n df u r t h e ri n c u -
bated for 30 min at 37°C to collapse to trimers. The
samples were then placed in MINI-Dialysis units (Pierce,
Rockford, IL) and dialyzed into PBS at pH 7.6 contain-
ing 5, 1, 0.2, 0.04, or 0.008 mM DTT. Samples were
removed for oligomerization and oxidation state analysis
using native and denaturing PAGE as described pre-
viously [21] after 6 and 18 hrs of dialysis. Dialysis buffer
was replenished at 6, 12, and 18 hrs with newly formu-
lated buffer containing fresh DTT. For native PAGE
analysis, samples were diluted in concentrated native gel
loading buffer and immediately subjected to electro-
phoresis or treated with 10 mM thiol-inactivating agent
N-ethylmaleimide (NEM) for 20 min at 37°C and frozen
at -20°C until electrophoresis. For non-reducing dena-
turing PAGE analysis, samples were treated with 10 mM
NEM at 37°C for 20 min and frozen at -20°C until elec-
trophoresis. Samples were denatured at 85°C for 20 min
in SDS-PAGE gel loading buffer without reducing
agents. The assignments of trimers, hexamers, and octa-
decamers in native gels were independently confirmed
using native mass spectrometry [21] and gel filtration
chromatography [9]. The oligomerization states of nona-
mers (9 mers) and dodecamers (12 mers) were extrapo-
lated from linear fitting of graphs in which the
migration distances of the known trimers, hexamers,
and octadecamers in native gels were plotted against the
natural log of monomer number.
Oligomerization state of adiponectin reassembled in
glutathione-based redox buffers
Purified octadecameric adiponectin was first reduced in
10 mM DTT for 1 hr at 37°C. DTT was then removed
by 6 rounds of buffer exchange into PBS supplemented
with 5 mM reduced glutathione (GSH) using 30 kD
molecular weight cut off Amicon Ultra 0.5 mL centrifu-
gal filter units (Millipore, Billerica, MA). To completely
collapse 18 mers to trimers, the DTT-free samples were
then incubated in 50 mM glycine at pH 4 for at least 15
min at room temperature. The samples were subse-
quently neutralized back to pH 7 by a 12.8-fold dilution
in PBS to restore adiponectin concentration to 0.25 mg/
mL. Following neutralization, aliquots were placed in
different ratios of GSH and oxidized glutathione (GSSG)
corresponding to reduction potentials of -120, -140,
-160, -180, -200, and -220 mV. The Nernst equation for
GSH/GSSG couple, E = E°’ - (RT/nF)([GSH]
2/[GSSG]),
was applied to calculate the ratios of GSH and GSSG
needed to maintain reactions at specific reduction
potentials. The value of -240 mV was used for the GSH/
GSSG couple standard reduction potential [33]. The
total cysteine equivalents in each reaction was between
1 to 3 mM. The samples were incubated at 25°C for the
time indicated until the ratios of dimers to monomers
reached equilibrium. Upon proceeding to completion,
the reactions were quenched in 10 mM NEM and stored
at -20°C until analyses. The portion of the procedure
from DTT removal to reaction quenching by NEM was
carried out in an anaerobic chamber (Coy Laboratory
Products, Grass Lake, MI) using degassed buffers to
minimize oxidation by atmospheric oxygen. Experiments
in which the reduction potentials were stretched from
-155 mV to +40 mV differed from the rest in two
aspects: DTT was removed by dialysis into PBS at pH
7.6 and total concentrations of glutathione were 10 mM.
To assess the effect of glutathione concentration on
adiponectin oligomerization, reduced trimers were pre-
pared following removal of DTT using centrifugal filter
units as described above and incubated in 2, 5, 10, or
15 mM total glutathione for indicated amounts of time
at room temperature with reduction potential main-
tained at -120 mV. In addition to oligomerization and
oxidation state analysis by PAGE and Coomassie stain-
ing, aliquots of the reactions were subjected to non-
reducing denaturing SDS-PAGE, transferred to nitrocel-
lulose membranes, and probed for glutathionylation of
adiponectin using an anti-GSH primary antibody (Arbor
Assays, Ann Arbor, MI) followed by a an infrared con-
jugated secondary antibody (LI-COR Biosciences, Lin-
coln, NE)
Oligomerization state of adiponectin reassembled in
presence of diamide
Purified adiponectin was collapsed to trimers by sequen-
tial incubations at 37°C in 10 mM DTT for 1 hr at pH
7 and 50 mM glycine for 30 min at pH 4. The samples
were neutralized by dilution in PBS and diamide was
added to experimental groups at a final concentration of
25 mM prior to dialysis against PBS. Equal volumes of
20 mM NEM were added at the end of each time point.
Oligomerization and oxidation states were determined
as described above.
Reassembly of HMW adiponectin from hexamers treated
with bME
Hexamers were generated by treating purified HMW
adiponectin with 50 mM glycine at pH 4 and incubated
at 37°C for at least 15 min. Upon neutralization in Tris-
base, bME was added to the reactions at final concen-
trations of 100 μM, 500 μMa n d5m Ma n di n c u b a t e d
for 4 hrs at 25°C. At each time point, aliquots were
removed for native and non-reducing denaturing PAGE.
Samples for non-reducing SDS-PAGE were first treated
with 20 mM NEM prior to heat denaturation. In sepa-
rate experiments, bME-mediated reassembly reactions
were performed after the samples were neutralized by
Briggs et al. BMC Biochemistry 2011, 12:24
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Page 10 of 12dialysis against PBS at pH 7 for 3 hrs instead of addition
of Tris-base.
Native and denaturing PAGE analysis of adiponectin
oligomers
Adiponectin oligomers were fractionated in 7% polyacry-
lamide gels under native conditions as previously
described [21]. The oxidation states of the cysteine resi-
due near the N-terminus of adiponectin were deter-
mined by non-reducing denaturing PAGE [21]. All
experiments were performed minimally three times, and
figures presented are representative of the results.
Additional material
Additional file 1: Supplemental Figure S1. Redox titration of
adiponectin oligomerization in glutathione-based redox buffers
with extended range of reduction potential. The figure and
associated legend are combined in a single PDF file. The complete file
name is Figure S1.pdf
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